西布曲明——又一种有缺陷的减肥药。 - Suppr

Suppr

超能文献

Sibutramine--another flawed diet pill.

作者信息

Curfman Gregory D, Morrissey Stephen, Drazen Jeffrey M

出版信息

N Engl J Med. 2010 Sep 2;363(10):972-4. doi: 10.1056/NEJMe1007993.

DOI:10.1056/NEJMe1007993

PMID:20818908

Abstract

摘要

相似文献

Sibutramine--another flawed diet pill.

N Engl J Med. 2010 Sep 2;363(10):972-4. doi: 10.1056/NEJMe1007993.

Sibutramine: balancing weight loss benefit and possible cardiovascular risk.

Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):337-41. doi: 10.1016/j.numecd.2008.03.008. Epub 2008 May 27.

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

N Engl J Med. 2010 Sep 2;363(10):905-17. doi: 10.1056/NEJMoa1003114.

Weight-loss drug fattens heart risks.

Consum Rep. 2003 Dec;68(12):57.

Withdrawal of sibutramine in Europe.

BMJ. 2010 Feb 9;340:c824. doi: 10.1136/bmj.c824.

Sibutramine: cardiovascular events.

Prescrire Int. 2010 Jun;19(107):125.

Sibutramine (Meridia) withdrawn.

Med Lett Drugs Ther. 2010 Nov 1;52(1350):88.

Controversy about the cardiovascular safety of sibutramine.

Drug Saf. 2010 Jul 1;33(7):615-8. doi: 10.2165/11538810-000000000-00000.

[Questions surrounding sibutramine for obesity].

Rev Med Suisse. 2010 Jan 13;6(231):76.

Proteome changes in rat plasma in response to sibutramine.

Proteomics. 2011 Apr;11(7):1300-12. doi: 10.1002/pmic.201000664. Epub 2011 Feb 17.

引用本文的文献

Defining Predictors of Weight Loss Response to Lorcaserin.

J Clin Endocrinol Metab. 2023 Aug 18;108(9):2262-2271. doi: 10.1210/clinem/dgad139.

Combined Acupoints for the Treatment of Patients with Obesity: An Association Rule Analysis.

Evid Based Complement Alternat Med. 2022 Mar 17;2022:7252213. doi: 10.1155/2022/7252213. eCollection 2022.

Looking for Crumbs in the Obesity Forest: Anti-obesity Interventions and Obesity-Associated Cardiometabolic Traits in the Mexican Population. History and Systematic Review With Meta-Analyses.

Front Med (Lausanne). 2021 Nov 3;8:665023. doi: 10.3389/fmed.2021.665023. eCollection 2021.

Mechanisms of Acupuncture Therapy for Simple Obesity: An Evidence-Based Review of Clinical and Animal Studies on Simple Obesity.

Evid Based Complement Alternat Med. 2019 Feb 3;2019:5796381. doi: 10.1155/2019/5796381. eCollection 2019.

Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis.

PLoS Med. 2016 Aug 16;13(8):e1002101. doi: 10.1371/journal.pmed.1002101. eCollection 2016 Aug.

Intragastric Balloon for Overweight Patients.

JSLS. 2016 Jan-Mar;20(1). doi: 10.4293/JSLS.2015.00107.

Triiodothyronine regulates distribution of thyroid hormone receptors by activating AMP-activated protein kinase in 3T3-L1 adipocytes and induces uncoupling protein-1 expression.

Mol Cell Biochem. 2014 Aug;393(1-2):247-54. doi: 10.1007/s11010-014-2067-6. Epub 2014 Apr 26.

Sibutramine promotes amygdala activity under fasting conditions in obese women.

Psychopharmacology (Berl). 2012 Jun;221(4):693-700. doi: 10.1007/s00213-011-2615-7. Epub 2011 Dec 24.

A two-year randomized trial of obesity treatment in primary care practice.

N Engl J Med. 2011 Nov 24;365(21):1969-79. doi: 10.1056/NEJMoa1109220. Epub 2011 Nov 14.

Cost-effectiveness of pharmacotherapy to reduce obesity.

PLoS One. 2011;6(10):e26051. doi: 10.1371/journal.pone.0026051. Epub 2011 Oct 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Sibutramine--another flawed diet pill.

N Engl J Med. 2010 Sep 2;363(10):972-4. doi: 10.1056/NEJMe1007993.

Sibutramine: balancing weight loss benefit and possible cardiovascular risk.

Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):337-41. doi: 10.1016/j.numecd.2008.03.008. Epub 2008 May 27.

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

N Engl J Med. 2010 Sep 2;363(10):905-17. doi: 10.1056/NEJMoa1003114.

Weight-loss drug fattens heart risks.

Consum Rep. 2003 Dec;68(12):57.

Withdrawal of sibutramine in Europe.

BMJ. 2010 Feb 9;340:c824. doi: 10.1136/bmj.c824.

Sibutramine: cardiovascular events.

Prescrire Int. 2010 Jun;19(107):125.

Sibutramine (Meridia) withdrawn.

Med Lett Drugs Ther. 2010 Nov 1;52(1350):88.

Controversy about the cardiovascular safety of sibutramine.

Drug Saf. 2010 Jul 1;33(7):615-8. doi: 10.2165/11538810-000000000-00000.

[Questions surrounding sibutramine for obesity].

Rev Med Suisse. 2010 Jan 13;6(231):76.

Proteome changes in rat plasma in response to sibutramine.

Proteomics. 2011 Apr;11(7):1300-12. doi: 10.1002/pmic.201000664. Epub 2011 Feb 17.

引用本文的文献

Defining Predictors of Weight Loss Response to Lorcaserin.

J Clin Endocrinol Metab. 2023 Aug 18;108(9):2262-2271. doi: 10.1210/clinem/dgad139.

Combined Acupoints for the Treatment of Patients with Obesity: An Association Rule Analysis.

Evid Based Complement Alternat Med. 2022 Mar 17;2022:7252213. doi: 10.1155/2022/7252213. eCollection 2022.

Looking for Crumbs in the Obesity Forest: Anti-obesity Interventions and Obesity-Associated Cardiometabolic Traits in the Mexican Population. History and Systematic Review With Meta-Analyses.

Front Med (Lausanne). 2021 Nov 3;8:665023. doi: 10.3389/fmed.2021.665023. eCollection 2021.

Mechanisms of Acupuncture Therapy for Simple Obesity: An Evidence-Based Review of Clinical and Animal Studies on Simple Obesity.

Evid Based Complement Alternat Med. 2019 Feb 3;2019:5796381. doi: 10.1155/2019/5796381. eCollection 2019.

Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis.

PLoS Med. 2016 Aug 16;13(8):e1002101. doi: 10.1371/journal.pmed.1002101. eCollection 2016 Aug.

Intragastric Balloon for Overweight Patients.

JSLS. 2016 Jan-Mar;20(1). doi: 10.4293/JSLS.2015.00107.

Triiodothyronine regulates distribution of thyroid hormone receptors by activating AMP-activated protein kinase in 3T3-L1 adipocytes and induces uncoupling protein-1 expression.

Mol Cell Biochem. 2014 Aug;393(1-2):247-54. doi: 10.1007/s11010-014-2067-6. Epub 2014 Apr 26.

Sibutramine promotes amygdala activity under fasting conditions in obese women.

Psychopharmacology (Berl). 2012 Jun;221(4):693-700. doi: 10.1007/s00213-011-2615-7. Epub 2011 Dec 24.

A two-year randomized trial of obesity treatment in primary care practice.

N Engl J Med. 2011 Nov 24;365(21):1969-79. doi: 10.1056/NEJMoa1109220. Epub 2011 Nov 14.

Cost-effectiveness of pharmacotherapy to reduce obesity.

PLoS One. 2011;6(10):e26051. doi: 10.1371/journal.pone.0026051. Epub 2011 Oct 27.